Live feed09:02:00·22dPRReleasevia Quantisnow+2A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million CompanyByQuantisnow·Wall Street's wire, on your screen.GTBP· GT Biopharma Inc.INKT· MiNK Therapeutics Inc.IPHA· Innate Pharma S.A. ADSIPSC· Century Therapeutics Inc.NKGN· NKGen Biotech Inc.Health Care
